Alexander Keenan, MA, MS, MD

Medication Preference for Injectable Versus Oral Antipsychotics in Patients With Schizophrenia: Results From a Patient-Reported Questionnaire From a Double-Blind Randomized Controlled Study

Introduction: Assessing factors that determine patients’ preferences for long-acting injectable (LAI) or oral antipsychotics could help reduce potential barriers to LAI use in schizophren...

Clifton Blackwood , MD;

Panna Sanga , MD;

Isaac Nuamah , PhD;

Arun K. Singh , MD, PhD, MCh, MNAMS;

Alexander Keenan , MA, MS, MD;

Srihari Gopal , MD;

Maju Mathews , MD;

11/22/2019

Drivers of Prescribing Long-Acting Injectable Antipsychotics to Patients with Schizophrenia

Long-acting injectable (LAI) antipsychotics are recommended by clinical guidelines for patients with schizophrenia who struggle with adherence and/or recurrent relapses. However, LAI util...

Alexander Keenan , MA, MS, MD;

Dee Lin , PharmD, MS;

Jason Shepherd , BA;

Hollie Bailey , BSc;

Jack Wright ;

Carmella Benson , MSc, MS, MSHP;

Katy Bacon ;

Edward S. Kim , MD, FACP, MBA;

10/08/2020